Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-19

Clinical Trial Update: Survival Effect of Hepato-celiac Lymphadenectomy In Primary or Relapsed Ovarian Cancer [NA]

View source ↗

Summary

Clinical trial investigating whether hepato-celiac lymphadenectomy affects survival in primary or relapsed epithelial ovarian cancer and related cancers. The st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Shanghai Gynecologic Oncology Group | Conditions: Epithelial Ovarian Cancer, Fallopian Tube Cancer | NA | Status: RECRUITING